As previously reported, BofA analyst Joshua Dennerlein downgraded Medical Properties Trust to Neutral from Buy with a price target of $10, down from $13. While the valuation is now "compelling," BofA says Medical Properties "has become a show me story" and the firm needs to see a positive resolution to Prospect and improvements in debt costs to be sure the company can avoid dilutive refinancing or asset sales.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MPW:
- Medical Properties Trust downgraded to Neutral from Buy at BofA
- 10 Stocks to Buy Before Their Ex-Dividend Dates Arrive, Week of March 13, 2023
- Medical Properties Stock (NYSE:MPW): Short Sellers Banking on a Dividend Cut
- Medical Properties Trust price target lowered to $14 from $17 at Barclays
- Medical Properties Trust Earnings Report: Did it Beat Expectations?
